Skip to content
DataLookout
Menu

Fred Hutchinson Cancer Center clinical trial pipeline

Get alerts when Fred Hutchinson Cancer Center's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

22 trials changed in the last 30 days: 0 stopped, 13 with notable changes, 9 with minor changes only.

  1. Notable: IL-18 Armored STEAP1 CAR T Cells · Metastatic Castration Resistant Prostate Cancer Start date pushed from Oct 31, 2026 to Dec 31, 2026 Fred Hutchinson Cancer CenterPhase 1 NCT07803653
  2. Notable: Tele-HOPE · Telehealth Pharmacist Opioid Patient Education Pilot Study Recruitment opened Fred Hutchinson Cancer CenterNot applicable NCT07737314
  3. Notable: Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial Start date pushed from Nov 1, 2026 to Dec 1, 2026 Fred Hutchinson Cancer CenterNot applicable NCT07615764
  4. Minor: One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe Study completion pushed from Dec 31, 2027 to May 31, 2028 Fred Hutchinson Cancer CenterNot applicable NCT07645352
  5. Minor: One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda Study completion pushed from Dec 31, 2027 to May 31, 2028 Fred Hutchinson Cancer CenterNot applicable NCT07390916
  6. Notable: Estrogen to Improve Quality of Life · Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial Start date pushed from Nov 1, 2026 to Dec 1, 2026 Fred Hutchinson Cancer CenterPhase 2 NCT07466498
  7. Notable: ICanQuit Smoking Cessation Among Hispanic Adults Start date pushed from Oct 15, 2026 to Dec 1, 2026 Fred Hutchinson Cancer CenterPhase 3 NCT06811038
  8. Notable: Nemtabrutinib and Lisocabtagene Maraleucel · Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Start date pushed from Oct 15, 2026 to Dec 1, 2026 Fred Hutchinson Cancer CenterPhase 2 NCT07194980
  9. Notable: FH-WT1-E50 TCR T Cells With Azacitidine · Minimal Residual Disease Positive Acute Myeloid Leukemia Start date pushed from Oct 15, 2026 to Dec 1, 2026 Fred Hutchinson Cancer CenterPhase 1 NCT07645469
  10. Notable: Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial Start date pushed from Oct 15, 2026 to Dec 1, 2026 Fred Hutchinson Cancer CenterNot applicable NCT06926062
  11. Notable: Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial Start date pushed from Oct 15, 2026 to Dec 1, 2026 Fred Hutchinson Cancer CenterNot applicable NCT07490860
  12. Minor: Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial Start date changed from estimate of Oct 15, 2026 to Oct 1, 2026 Fred Hutchinson Cancer CenterNot applicable NCT07176000
  13. Minor: Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation · High-Risk Hematologic Diseases Interventions modified Fred Hutchinson Cancer CenterPhase 2 NCT06013423
  14. Minor: Enfortumab Vedotin, Pembrolizumab and Quemliclustat · Unresectable Locally Advanced and Metastatic Urothelial Cancer Start date changed from estimate of Oct 15, 2026 to Oct 20, 2026 Fred Hutchinson Cancer CenterPhase 1/2 NCT07667335
  15. Minor: Improving Outcomes Assessment in Chronic GVHD Study completion pushed from Feb 2027 to Feb 2028 Fred Hutchinson Cancer CenterNot specified NCT00637689
  16. Minor: Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking Trial completed Fred Hutchinson Cancer CenterNot applicable NCT04409236
  17. Minor: Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial Primary completion pushed from Sep 30, 2026 to Feb 28, 2027 Fred Hutchinson Cancer CenterNot applicable NCT07052630
  18. Notable: Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya Recruitment opened Fred Hutchinson Cancer CenterNot applicable NCT07468695
  19. Notable: One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa Recruitment opened Fred Hutchinson Cancer CenterNot applicable NCT07645378
  20. Notable: Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant · Acute Leukemia or Myelodysplastic Syndrome (MDS) Primary completion pushed from Dec 31, 2027 to Dec 31, 2028 Fred Hutchinson Cancer CenterPhase 2 NCT03970096
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-02 NCT07908407 Remote Screening and Navigation to Increase Trial Enrollment, INVITE Trial Not Yet Recruiting
2026-10-21 NCT07887061 Tacabrutideg and Sonrotoclax, With Response-Guided Obinutuzumab, for the Treatment of… Phase 2 Not Yet Recruiting

Active trials by phase

Phase 1
11
Phase 1/2
9
Phase 2
30
Phase 3
1
Not charted: 45 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Get alerts when Fred Hutchinson Cancer Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free